News related to the ongoing COVID-19 pandemic with focus on the Nordic life science industry.
Updated on a regular basis.
A baby born at Skåne University Hospital, Sweden, last year tested positive for COVID-19 and a study of the case has now established that the baby was already infected whilst
AstraZeneca advances mass global rollout of COVID-19 vaccine through the multilateral COVAX initiative. Supply to 142 countries is underway as part of the effort to bring broad and equitable access
Pfizer and BioNTech have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on
In December 2020, SciLifeLab and the Knut and Alice Wallenberg Foundation (KAW), announced a call for a national program studying the effects of COVID-19 vaccines. 24 proposals were submitted and
The company’s qDBS dried blood spot system for home sample collection is being used in a nation-wide randomized clinical trial on the role of Vitamin D in COVID-19 run by
A joint project by VTT, the Tampere University and THL has studied the mechanisms of the droplet and aerosol transmission of COVID-19 and the methods for reducing the risk of
Johnson & Johnson has announced that Janssen-Cilag International has submitted a conditional Marketing Authorization Application (cMAA) to the European Medicines Agency (EMA) seeking authorization for its investigational single-dose Janssen COVID-19
As many as 96 percent of those infected with COVID-19 retain protective antibodies for at least nine months after confirmed infection. This is shown by a study from Danderyd Hospital
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals 18 years of age and older,
The Ministry of Healthcare of Republic of Azerbaijan granted an approval to conduct clinical trials of the combined use of the Sputnik V and the COVID 19 vaccine AstraZeneca in Azerbaijan. Previously, the
AstraZeneca and IDT Biologika are exploring options to accelerate output of finished COVID-19 Vaccine AstraZeneca in the second quarter of 2021. AstraZeneca and IDT Biologika also intend to strengthen Europe’s
AstraZeneca’s COVID-19 vaccine has been granted a conditional marketing authorization (CMA) in the European Union (EU) for active immunization to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of
Scientists have published an action plan for pan-European defense against new SARS-CoV-2 variants in the Lancet. The B.1.1.7 and B1.351 variants, first identified in the UK and South Africa, respectively,
Danish research shows that most of the people hospitalized with COVID-19 had impaired cardiac function. A study that included people with COVID-19 hospitalized in Region Zealand and the Capital Region
AdaptVac has announced the publication of strong virus neutralization animal proof-of-concept data for its capsid virus like particle (cVLP) based SARS-CoV-2 subunit vaccine in Nature Communications. The vaccine elicited antibodies
Swedish medtech start-up Capitainer has closed a share issue of SEK 31 million to roll out its new qDBS dried blood spot testing system. Led by Sciety the target was
